Bayer AG - ADR
BAYRY
Market Cap$26.72B
Close$
$2.06
69.8% downside
Current Fair Value
69.8% downsideOvervalued by 69.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.72 Billion |
|---|---|
| Enterprise Value | $62.32 Billion |
| Dividend Yield | $0.022927 (0.457475566645872%) |
| Earnings per Share | $-0.65 |
| Beta | 0.98 |
| Outstanding Shares | 3,929,680,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.26 |
|---|---|
| PEG | 109.57 |
| Price to Sales | 0.62 |
| Price to Book Ratio | 0.85 |
| Enterprise Value to Revenue | 1.33 |
| Enterprise Value to EBIT | 18.29 |
| Enterprise Value to Net Income | -71 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 1.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bayer AG
CEO: Werner Baumann Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Ani...